In a filing, Avidity Biosciences Inc revealed its CSTO Flanagan W. Michael unloaded Company’s shares for reported $4.5 million on Sep 11 ’24. In the deal valued at $40.40 per share,111,394 shares were sold. As a result of this transaction, Flanagan W. Michael now holds 60,871 shares worth roughly $2.54 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, McCarthy Teresa sold 25,000 shares, generating $1,010,042 in total proceeds. Upon selling the shares at $40.40, the Chief Human Resources Officer now owns 57,171 shares.
Before that, WILLIAM MICHAEL FLANAGAN bought 111,394 shares. Avidity Biosciences Inc shares valued at $4,543,761 were divested by the Officer at a price of $40.79 per share.
Barclays initiated its Avidity Biosciences Inc [RNA] rating to an Overweight in a research note published on August 28, 2024; the price target was $63. A number of analysts have revised their coverage, including BofA Securities’s analysts, who began to cover the stock in early May with a ‘”a Buy”‘ rating. Cantor Fitzgerald began covering RNA with “an Overweight” recommendation on March 14, 2024. Evercore ISI revised its rating on May 22, 2023. It rated RNA as “an Outperform” which previously was an “an In-line”.
Price Performance Review of RNA
On Monday, Avidity Biosciences Inc [NASDAQ:RNA] saw its stock jump 0.10% to $41.75. Over the last five days, the stock has gained 2.43%. Avidity Biosciences Inc shares have risen nearly 361.33% since the year began. Nevertheless, the stocks have risen 472.70% over the past one year. While a 52-week high of $48.80 was reached on 07/29/24, a 52-week low of $4.82 was recorded on 01/02/24. SMA at 50 days reached $43.60, while 200 days put it at $26.42.
Levels Of Support And Resistance For RNA Stock
The 24-hour chart illustrates a support level at 41.11, which if violated will result in even more drops to 40.47. On the upside, there is a resistance level at 42.42. A further resistance level may holdings at 43.09. The Relative Strength Index (RSI) on the 14-day chart is 47.42, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.18, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 57.53%. Stochastics %K at 39.64% indicates the stock is a holding.
How much short interest is there in Avidity Biosciences Inc?
A steep rise in short interest was recorded in Avidity Biosciences Inc stocks on 2024-08-30, dropping by -2.14 million shares to a total of 10.81 million shares. Yahoo Finance data shows the prior-month short interest on 2024-07-31 was 12.95 million shares. There was a decline of -19.84%, which implies that there is a negative sentiment for the stock.
